The COVID Vaccine: A Shot in the Arm for Fertility Treatment?
Appeared in BioNews 1082
The rollout of COVID vaccination programmes has brought with it a renewed hope of a return to normality but has also raised questions about the impact of vaccination on fertility treatment and pregnancy.
To help explain and clarify the advice to fertility patients and clinicians, and to fight misinformation spreading online, the Progress Educational Trust (PET) – the charity that publishes BioNew – held an online event. The COVID-19 Vaccine: A Shot in the Arm for Fertility Treatment? was chaired by PET s director Sarah Norcross, and featured speakers outlining the approaches taken by UK, EU and US bodies.
Ershad Kamol | Published: 23:59, Feb 02,2021
Rubbish collectors dump and sort wastes adjacent to a road of Mitford Hospital in Dhaka prompting concerns for hygiene and cleanliness. The photo was taken on Tuesday. Sony Ramany
The air quality in the city of Dhaka has been extremely hazardous for public health for over 10 years as the government could not contain the sources of pollution despite taking various projects and plans.
According to greens and public health experts, the air quality score has remained four to seven times higher than the acceptable limit of 50 for most of the year for many years even after a Tk 802.25 crore clean air and sustainable environment project was implemented for the city.
Even as vaccines are being rolled out in India in phases, gynaecologists and fertility experts in India have urged people to delay planning a pregnancy until two months after they get the vaccine against Covid-19.
Meanwhile, the Centre has stated that pregnant and lactating women have not been part of any Covid vaccine clinical trial so far and should not receive the vaccine at this time.
Resuming Treatment: What Can European Countries Learn from One Another?
Appeared in BioNews 1077
As we move towards the end (fingers crossed!) of a staggered and fractured response to a global pandemic, the final session of PET s annual conference asked what European countries can learn from one other in the resumption of fertility treatment.
The session, sponsored by the European Society of Human Reproduction and Embryology (ESHRE), was chaired by that organisation s former chair Dr Anna Veiga, who is also coordinator of ESHRE s COVID-19 Working Group. Covering Belgium, Italy and Ireland, three speakers from the working group built a picture of what is happening across Europe, and detailed the work that ESHRE has done to guide fertility services during the pandemic. Dr Veiga explained that their work has included guidance for clinics, practical support for professionals and patients by providing information, and improving knowledge by gathering data on the impact of COVID-19 on a